Towa Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TWAPF research report →
Price Chart
About the company
Operating in Japan, Towa Pharmaceutical Co. , Ltd. and its subsidiaries are engaged in the research, development, production, and sale of prescription drugs, active pharmaceutical ingredients, and intermediates.
- CEO
- Itsuro Yoshida
- IPO
- 2009
- Employees
- 4,923
- HQ
- Kadoma, JP
Get TickerSpark's AI analysis on TWAPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $1.28B
- P/E
- 21.46
- Fwd P/E
- 0.06
- PEG
- -0.44
- P/S
- 0.63
- P/B
- 0.97
- EV/EBITDA
- 9.11
- Div Yield
- 2.22%
- Gross Margin
- 36.27%
- Op Margin
- 8.72%
- Net Margin
- 2.95%
- ROE
- 4.53%
- ROIC
- 2.83%
Latest fiscal year · YoY change
- Revenue
- $275.43B+6.1%
- Gross Profit
- $99.73B+5.3%
- Op Income
- $23.25B
- Net Income
- $5.28B-72.2%
- EPS
- $107.05-72.2%
- OCF Growth
- +30.9%
- FCF Growth
- +204.9%
- 52W High
- $26.00
- 52W Low
- $16.83
- 50D MA
- $25.98
- 200D MA
- $19.94
- Beta
- -0.09
- RSI (14)
- 99
- Avg Volume
- 1
No earnings-call transcripts are available for TWAPF yet.
- Free Float
- 46.7%
- Shares Outstanding
- 49.23M
- Float Shares
- 23.01M
Our TWAPF coverage
Recent articles, reports, and earnings notes.
No research on TWAPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TWAPF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.